Improving treatment for early diabetic eye disease
Treating early stage diabetic retinopathy
This study is looking at how to spot early signs of eye problems in people with diabetes before they can see any damage, and it’s testing whether a medication called levodopa can help protect their vision by treating these early issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Veterans Health Administration NIH-funded |
| Lab location | 1 site (Decatur, UNITED STATES) |
| Project ID | NIH-11092690 on NIH RePORTER |
What this research studies
This research focuses on diabetic retinopathy, a common cause of vision loss in individuals with diabetes. It aims to identify early signs of retinal dysfunction before visible damage occurs, using non-invasive techniques like electroretinograms. The study explores the potential of using levodopa, a dopamine precursor, to treat early neuronal dysfunction in the retina, which may prevent the progression to more severe vascular damage and vision loss. By treating patients earlier, the research seeks to improve outcomes for those at risk of developing diabetic retinopathy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes who show early signs of retinal dysfunction but do not yet have clinically visible diabetic retinopathy.
Not a fit: Patients who already have advanced diabetic retinopathy or significant vision loss may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier interventions that prevent vision loss in patients with diabetes.
How similar studies have performed: Previous studies have shown promising results using similar approaches to treat early retinal dysfunction in diabetic patients.
Where this research is happening
Decatur, UNITED STATES
- Veterans Health Administration — Decatur, United States (Active)
Researchers
- Principal investigator: Pardue, Machelle T. — Veterans Health Administration
- Study coordinator: Pardue, Machelle T.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.